Toutes les études
RecrutementOBSERVATIONNEL

Augmentation de la Clairance Rénale en Soins Neurocritiques

This study is for adults admitted to intensive care with serious brain conditions like stroke, brain injury, or infections. Sometimes, in these conditions, kidneys can work unusually fast – this is called Augmented Renal Clearance (ARC). When kidneys work too quickly, medicines, like those for seizures or infections, might be cleared from the body faster than expected. This could mean patients aren't getting enough medicine for it to work properly. Researchers want to understand how often ARC happens in these patients, how long it lasts, and what causes it. By collecting blood and urine samples, they hope to find better ways to detect ARC and figure out the best doses for important medicines. The goal is to improve how doctors care for patients with these life-threatening brain illnesses.

En un coup d'œil

Statut
Recrutement
Sponsor
Université de l'Alberta
Objectif d'inscription
512
Démarrer
01 Oct 2021
Achèvement estimé
30 Sep 2026

De quoi parle cette étude ?

Imagine your kidneys are like a filter, cleaning your blood and getting rid of waste products, including medicines. In some serious health situations, particularly after severe brain injuries, strokes, or infections affecting the brain, a person's kidneys might start working much faster than usual. This is called 'Augmented Renal Clearance' (ARC), which simply means 'increased kidney clearing'.

When kidneys are working overtime like this, they can clear medicines from the body very quickly. This can be a problem because if a patient is taking important medicines – like antibiotics for an infection or drugs to control seizures – those medicines might not stay in their system long enough or at a high enough level to be fully effective. Doctors often don't easily spot when a patient's kidneys are doing this, so they might accidentally be giving doses of medicine that are too low to work properly.

This research aims to bridge this gap in our understanding. The study will look at how common ARC is in patients with serious brain conditions in intensive care. By studying blood and urine samples, researchers hope to understand what causes ARC and how it affects important medicines. The ultimate goal is to help doctors more easily identify patients with ARC and provide clear guidance on how to adjust medicine doses so patients get the most effective treatment possible, improving their recovery and overall health.

Points clés

  • This study investigates how serious brain conditions might affect kidney function.
  • It focuses on 'Augmented Renal Clearance' (ARC), where kidneys work extra fast.
  • ARC can cause medicines to leave the body too quickly, making them less effective.
  • Researchers will collect blood and urine samples to understand ARC and its impact on medicine levels.
  • The goal is to improve medicine dosing for patients with serious brain conditions.
  • Participation involves routine sampling and does not involve new treatments.

Qui peut être éligible ?

This study is looking for adults aged between 18 and 85 years old. You would need to be admitted to an intensive care unit (ICU) at one of the hospitals taking part in the study. You would also need to have a serious brain condition, such as a major stroke, a severe brain injury, uncontrolled seizures, or a brain infection like meningitis.

Before joining, you'll be asked to give your consent, meaning you agree to take part after understanding all the details. For practical reasons, you'd also need to have a special tube called a Foley catheter for collecting urine samples comfortably.

However, you wouldn't be able to join if you are in prison. Also, if your doctors expect you to be in the ICU for less than three days, you wouldn't be able to participate, as the study needs enough time to monitor your condition and take samples.

Cet étude pourrait-elle vous convenir ?

Répondez à ces questions rapides pour voir si vous êtes éligible. Ceci est un guide uniquement — l'équipe de recherche prend la décision finale.

  1. Are you aged between 18 and 85 years old?
  2. Are you currently in an intensive care unit (ICU) for a serious brain condition (like stroke, brain injury, seizures, or infection)?
  3. Do you have a Foley catheter in place (a small tube for urine collection)?
  4. Is it expected you will be in the ICU for at least 3 days?
Répondez à chaque question pour voir votre résultat.

En quoi consiste la participation ?

If you decide to take part in this study, the doctors and nurses will collect urine and blood samples from you. These samples will help them understand how your kidneys are working and how certain medicines are being processed by your body. This will include tests to see if your kidneys are working extra fast (Augmented Renal Clearance, or ARC).

If you are receiving specific antibiotics or anti-seizure medications, additional blood samples may be taken to check the levels of these drugs in your system. This helps researchers understand if the medicines are at the right concentration to be effective, especially if you have ARC. The study does not involve any new or experimental medications; it focuses on understanding how your body handles the standard treatments you are already receiving. There are no extra visits or follow-up appointments required beyond your usual hospital care. The total duration of your participation would be for as long as you are in the intensive care unit where the samples are collected.

Risques et avantages potentiels

Taking part in this study might help doctors learn more about how kidneys affect medicine doses, which could lead to better treatment for future patients with serious brain conditions. Participants might not directly benefit from being in the study, as the findings will mainly help guide care for others in the future. The main risks involve a few extra blood and urine samples, which might cause some mild discomfort or bruising, similar to routine hospital tests. You are free to withdraw from the study at any time without giving a reason, and this will not affect your medical care in any way.

Emplacements (3)

  • UK HealthCare
    Code postal vérifié
    Lexington, United States· Recrutement
  • The Ohio State University Wexner Medical Center
    Code postal vérifié
    Columbus, États-Unis· Recrutement
  • University of Alberta Hospital
    Code postal vérifié
    Edmonton, Canada· Recrutement

Questions fréquentes

What is 'Augmented Renal Clearance'?

It means your kidneys are working faster than usual, clearing medicines from your body more quickly.

Why is this important?

If kidneys work too fast, medicines might not stay in your system long enough to work properly, leading to less effective treatment.

Will I receive new medicines?

No, this study focuses on how your body handles standard medicines you are already being given, not new ones.

What do I have to do if I join?

You would provide blood and urine samples, which are collected during your stay in intensive care.

Puis-je quitter l'étude à tout moment ?

Yes, you can withdraw at any point without it affecting your medical care.

Comment en savoir plus

Sherif H Mahmoud, BSc (Pharm), MSc, PhD, FNCS

Parlez toujours à votre médecin généraliste ou spécialiste avant de décider de participer à une étude.

Intéressé à participer ?

Inscrivez votre intérêt

Partagez vos coordonnées et l'équipe de recherche pour "Augmentation de la Clairance Rénale en Soins Neurocritiques… vous contactera si vous êtes éligible. Consultez toujours votre médecin avant d'accepter de participer.

Discussion

Discussion communautaire

Propulsé par notre forum à community.patient.info. Veuillez être respectueux — ceci n'est pas un avis médical.